BridgeMD
New treatment option for Stage I Pancreatic Cancer AJCC v8
Official title A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov ID: NCT07651358
What this study is testing
- What it's testing
- This clinical trial studies whether a tailored, web-based program (web portal), Community for Physical Activity and Supportive Nutrition Strategies (COMPASS), can be used to improve exercise and dietary changes in patients with stage I-III pancreatic cancer who are receiving chemotherapy before surgery (neoadjuvant). Pancreatic cancer is a rare and understudied cancer, particularly in the area of promoting a healthy lifestyle to preserve physical and mental well-being during a long and difficult treatment regimen.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older on date of enrollment
- Confirmed by review of the date of birth as documented in the electronic medical record (EMR) and subsequently recorded in a case report form (CRF)
- Diagnosed with stage I-III pancreatic cancer
- Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm
- Scheduled to receive neoadjuvant chemotherapy at Oregon Health \& Science University (OHSU)
You likely can't join if
- Cognitive difficulties that preclude answering the survey questions, participating in the intervention, or giving informed consent
- In the event of a suspected undeclared cognitive impairment, it will be confirmed by physician clearance or professional opinion of the Principal...
- A medical condition, movement or neurological disorder, or medication use that contraindicates participation in light intensity exercise
- Confirmed by a combination of reviewing the EMR, and self-report during the initial screening call. If in the professional opinion of the Principal...
- Not fluent in English and therefore incapable of answer survey questions, reading the intervention web portal, and providing informed consent in...
- Confirmed verbally with the participant and response documented in the Participant Tracking database
See the full eligibility criteria
- Age 18 years or older on date of enrollment
- Confirmed by review of the date of birth as documented in the electronic medical record (EMR) and subsequently recorded in a case report form (CRF)
- Diagnosed with stage I-III pancreatic cancer
- Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm
- Scheduled to receive neoadjuvant chemotherapy at Oregon Health \& Science University (OHSU)
- Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm
- Willing to adhere to the study protocol
- Confirmed verbally with the participant and response documented in the Participant Tracking database
- Cognitive difficulties that preclude answering the survey questions, participating in the intervention, or giving informed consent
- In the event of a suspected undeclared cognitive impairment, it will be confirmed by physician clearance or professional opinion of the Principal Investigators, Dr. Kerri Winters-Stone and/or Dr. Jackilen Shannon
- A medical condition, movement or neurological disorder, or medication use that contraindicates participation in light intensity exercise
- Confirmed by a combination of reviewing the EMR, and self-report during the initial screening call. If in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone or Dr. Jackilen Shannon...
- Not fluent in English and therefore incapable of answer survey questions, reading the intervention web portal, and providing informed consent in English
- Confirmed verbally with the participant and response documented in the Participant Tracking database
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.